Vanderbilt Ingram Cancer Center

  • Vanderbilt University

    Probing the pathogenesis of leukemia

    A new mouse model reveals gene clusters important in a treatment-resistant form of leukemia. Read More

    Feb 27, 2014

  • Vanderbilt University

    Studies shed new light on breast cancer development

    Rebecca Cook, Ph.D., assistant professor of Cancer Biology, has spent her life trying to understand what makes things grow, from seedlings in soil to tumor cells in the body. Read More

    Feb 20, 2014

  • Vanderbilt University

    Agreement sets stage for enhanced My Cancer Genome

    Vanderbilt-Ingram Cancer Center (VICC) and GenomOncology have announced an agreement for the exclusive commercial development of a decision support tool based on My Cancer Genome, an online precision cancer medicine knowledge resource for physicians, patients, caregivers and researchers. Read More

    Feb 13, 2014

  • Vanderbilt University

    Photo: Blackhawk visits

    The musical group Blackhawk recently performed for patients at Vanderbilt-Ingram Cancer Center. The group raises funds for the Cancer Center in honor of former bandmate Van Stephenson, who died from melanoma. Read More

    Feb 13, 2014

  • Vanderbilt University

    VICC debuts lung cancer screening program

    Vanderbilt-Ingram Cancer Center has launched a new lung cancer screening program to provide low-dose CT scans for patients at high risk for the deadly disease. Current or former smokers ages 55 to 74 who have a history of 30 or more pack years of smoking are eligible for the scans. Read More

    Jan 30, 2014

  • Vanderbilt University

    Vanderbilt-Ingram Cancer Center receives $100,000 ovarian cancer research grant from Kay Yow Cancer Fund

    L-r: Lawrence Marnett, Mary Geddes Stahlman Professor of Cancer Research; Vanderbilt women’s head basketball coach Melanie Balcomb; Susan Donohoe, executive director of the Kay Yow Cancer Fund; Mayor Karl Dean; Vanderbilt-Ingram Cancer Center Director Jennifer Pietenpol; and Assistant Professor of Obstetrics and Gynecology Dineo Khabele were on hand for… Read More

    Jan 21, 2014

  • Vanderbilt University

    Targeting tumor “supply lines”

    A metabolic enzyme plays a crucial role in vascular development and may be a good target for cancer therapies. Read More

    Dec 18, 2013

  • Vanderbilt University

    Research climate must be enhanced: NCI director

    The director of the National Cancer Institute, Harold Varmus, M.D., told an overflow crowd at this year’s Orrin Ingram Distinguished Lecture that he is concerned about the climate for discovery research in the United States. Read More

    Dec 5, 2013

  • Vanderbilt University

    Therapeutic target for synovial sarcoma

    Inhibitors of a signaling pathway that is critical to synovial sarcoma tumorigenesis may be useful treatments for this aggressive cancer. Read More

    Nov 21, 2013

  • Vanderbilt University

    Photo: Cancer survivorship celebration

    More than 650 cancer survivors, family members and cancer health care providers attended Vanderbilt-Ingram Cancer Center’s Cancer Survivorship Celebration earlier this month during a special evening dinner and concert at the Loveless Barn in Nashville. Read More

    Nov 21, 2013

  • Vanderbilt University

    National Cancer Institute director set for Discovery Lecture

    The director of the National Cancer Institute, Harold Varmus, M.D., will deliver the next Flexner Discovery Lecture on Thursday, Nov. 21. His lecture, “New Directions in Cancer Research,” will begin at 4 p.m. in 208 Light Hall. Read More

    Nov 14, 2013

  • Vanderbilt University

    Family’s support enhances cancer research training

    John F. Brock III, chairman and CEO of Coca-Cola Enterprises, his wife, Mary, and their three children have established an endowment to support an oncology fellowship at Vanderbilt-Ingram Cancer Center. The Brock Family Fellowship will provide financial assistance long into the future for young physicians, postdoctoral students and medical investigators who are furthering their training in cancer research. Read More

    Nov 14, 2013

  • Vanderbilt University

    Breast SPORE lands NCI renewal

    Vanderbilt-Ingram Cancer Center’s Breast Specialized Program of Research Excellence (SPORE) has been awarded a third round of funding from the National Cancer Institute (NCI). Read More

    Nov 7, 2013

  • Vanderbilt University

    VICC debuts new Center for Cancer Targeted Therapies

    Vanderbilt-Ingram Cancer Center leaders formally dedicated the space for the new Center for Cancer Targeted Therapies (CCTT), located in the Infusion Center on the second floor of The Vanderbilt Clinic, at a special ribbon-cutting held during last week’s fall meeting of the Cancer Center’s Board of Overseers. Read More

    Oct 31, 2013

  • Vanderbilt University

    Concert highlights upcoming cancer survivorship celebration

    There are nearly 13 million cancer survivors in the United States thanks to intensive cancer research, improved treatments and cancer support programs. In celebration of cancer survivors and those patients who have passed away from the disease, Vanderbilt-Ingram Cancer Center, in partnership with Gilda’s Club Nashville, will host the 2013 Cancer Survivorship Celebration. Read More

    Oct 10, 2013

  • Vanderbilt University

    Probing mutant EGF receptor regulation

    Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies. Read More

    Oct 10, 2013

  • Vanderbilt University

    Sosman named one of ‘hottest’ researchers in U.S.

    Jeffrey Sosman, M.D., professor of Medicine, Ingram Chair for Cancer Research and director of the Vanderbilt Melanoma Program, was named one of the Hottest Scientific Researchers of the last year by Thomas Reuters Science Watch. Read More

    Sep 26, 2013

  • Support group cares for cancer caregivers

    Support group cares for cancer caregivers

    Physical fatigue, anxiety and emotional distress are just some of the symptoms that caregivers may experience while undertaking the hard work of helping a friend or loved one cope with cancer. Read More

    Sep 26, 2013

  • Deciphering DNA code

    VU study identifies DNA changes in drug-resistant cancer cells

    Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines. Read More

    Sep 12, 2013

  • Vanderbilt University

    Tumor factor spurs blood vessel growth

    A newly identified factor regulates blood vessel growth in colorectal tumors and could be a promising target for cancer therapies. Read More

    Aug 26, 2013